Skip to content Skip to sidebar Skip to footer

Newsletter

Large Caps

Coles Jumps on Full-Year Results: What Investors Need to Know

Coles (ASX: COL): Stability Today, Efficiency Gains Tomorrow Coles Group (ASX: COL) opened the day up nearly 4 percent at $21 after releasing its full year results, and the reaction tells us something important about how investors see this company. In a market where volatility and uncertainty dominate the headlines, Coles is being treated as a…

ByCharlie YouldenAugust 26, 2025

Skycity Entertainment Group (ASX:SKC): Is it on the same fatal path as Star Entertainment?

Is Skycity Entertainment Group (ASX:SKC) on the same path as Star? On one hand, it may sound preposterous as it has revenues just about the same as it was pre-COVID and it is profitable. The other, it announced a $240m capital raising the same day as its annual results and is seeing customers spend less…

ByNick SundichAugust 26, 2025

6 of the best annual results on the ASX in FY25 and 6 of the worst!

Each reporting season, we like to recap some of the best annual results on the ASX and some of the worst as well. Amidst all the companies, it is easy for investors to get lost amidst the mire of information. And so we like to single out particular companies that impressed and others that did…

ByNick SundichAugust 26, 2025

Breville (ASX:BRG): Will consumer demand for $4500 coffee machines offset the impact of Trump’s tariffs?

Breville (ASX:BRG) is one of those consumer stocks caught in the crosshairs of Trump's tariffs and fell 30% in 2 months earlier in 2025. But its most recent annual results have given hope that customers may be willing to pay a premium for its goods. What are the Best ASX Consumer Stocks to invest in right…

ByNick SundichAugust 25, 2025

If you’re looking at insurance stocks as a safe investment, here’s why you might be mistaken

Insurance stocks may appear to only be up there with the banks in terms of money 'on the books'. But things aren't as easy as they may appear to be at first glance. What are the Best ASX Stocks to invest in right now? Check our buy/sell tips [sg_popup id="23914" event="click"][/sg_popup] How insurance stocks operate? In other words,…

ByNick SundichAugust 13, 2025

Telix SEC Subpoena Explained: Why the Stock Plunged 31%

What Investors Need to Know About the Telix SEC Subpoena What happens when a fast-growing biotech lands a major U.S. listing, then suddenly finds itself in the SEC’s crosshairs? That’s the question Telix Pharmaceuticals (ASX:TLX) investors are now asking after the company disclosed it had received a subpoena from the U.S. Securities and Exchange Commission.…

ByCharlie YouldenAugust 8, 2025

ResMed (ASX:RMD): Investors who bought the dip would be satisfied, but is there any growth left in this one?

ResMed (ASX:RMD) is one of the few ASX healthcare stocks that has successfully made it in the USA. And while Trump's tariffs have caused headaches for many healthcare stocks, ResMed might even be a beneficiary of them. Yes, there was a temporary dip in the share price, but shares are up more than 20% in…

ByNick SundichAugust 5, 2025

The $300m Star Entertainment rescue package promised it a lifeline, but its not a done deal and the company’s fate hangs in the balance

Back in April, a long awaited Star Entertainment rescue package was unveiled and the company was able to stave off administration...for a while. But the deal still is not done - which is to say not all the money has been received yet; and so the company's fate is hanging in the balance. Why Star Entertainment needed…

ByNick SundichJuly 31, 2025

IperionX (ASX:IPX): It has become a A$1.7bn company, all thanks for US demand for titanium

Five years ago, IperionX (ASX:IPX) was just another small cap treading water with a market cap of $2.7m. Even in April 2023, it was only a tenth of what is now at under $200m, but it has created spectacular wealth for long-term investors. And it didn't happen by accident or coincidence. Luck may have been…

ByNick SundichJuly 30, 2025

As ASX Reporting Season for FY25 Looms: Here’s An Investors Ultimate Guide

ASX Reporting Season is almost upon us once again. It is the most important time of the year for investors, a time many reconsider if their thesis still holds, many choose to buy into a stock or sell, some will receive dividends (either expectedly or unexpectedly) whilst others will be disappointed. While you may not…

ByNick SundichJuly 23, 2025

the Kick-ass Multipurpose WordPress Theme

Large Caps

Coles Jumps on Full-Year Results: What Investors Need to Know

Skycity Entertainment Group (ASX:SKC): Is it on the same fatal path as Star Entertainment?

6 of the best annual results on the ASX in FY25 and 6 of the worst!

Breville (ASX:BRG): Will consumer demand for $4500 coffee machines offset the impact of Trump’s tariffs?

If you’re looking at insurance stocks as a safe investment, here’s why you might be mistaken

Telix SEC Subpoena Explained: Why the Stock Plunged 31%

ResMed (ASX:RMD): Investors who bought the dip would be satisfied, but is there any growth left in this one?

The $300m Star Entertainment rescue package promised it a lifeline, but its not a done deal and the company’s fate hangs in the balance

IperionX (ASX:IPX): It has become a A$1.7bn company, all thanks for US demand for titanium

As ASX Reporting Season for FY25 Looms: Here’s An Investors Ultimate Guide

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Large Caps

Stocks in Spotlight

Add Your Heading Text Here